Jia-Hao Sun1, Lan Tan1,2,3, Hui-Fu Wang2, Meng-Shan Tan1, Lin Tan3, Jie-Qiong Li1, Wei Xu1, Xi-Chen Zhu2, Teng Jiang4, Jin-Tai Yu1,2,5. 1. Department of Neurology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, Qingdao, China. 2. Department of Neurology, Qingdao Municipal Hospital, Nanjing Medical University, Qingdao, China. 3. College of Medicine and Pharmaceutics, Ocean University of China, Qingdao, China. 4. Department of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. 5. Memory and Aging Center, Department of Neurology, University of California, San Francisco, CA, USA.
Abstract
BACKGROUND: Vascular dementia (VaD) is the second most common type of dementia. So far, little is known about the contribution of genetic polymorphisms to the risk of VaD. Many candidate genetic polymorphisms have been examined in a large number of studies. However, due to the conflicting results, the genetics of VaD is still behind the shadow. OBJECTIVE: We conducted a comprehensive meta-analysis on associations between genetic polymorphisms of any gene and VaD to investigate the genetics of VaD. METHOD: We sought the published studies of associations between any genetic polymorphism and VaD and critically appraised them. We assessed the effects of genetic models by calculating pooled odds ratios (ORs), investigating the origin of heterogeneity by subgroup analysis, and testing the robustness by random effect model and sensitivity analysis. RESULTS: 69 studies with 4,462 cases and 11,583 controls were included. We identified APOE ɛ2/ɛ3/ɛ4 and additional four genetic polymorphisms including MTHFR C677T, PON1 L55M, TGF-β1 +29C/T, and TNF-α -850C/T associated with VaD. Tested by random effect model and sensitivity analysis, the pooled results show nice robustness. CONCLUSIONS: Our comprehensive meta-analysis highlighted the genetic contribution to sporadic VaD. Because of the small amount of data on associations between genetic polymorphisms, except for APOE, and VaD, more studies are needed to test the existing genetic polymorphisms and detect other related genetic variants.
BACKGROUND:Vascular dementia (VaD) is the second most common type of dementia. So far, little is known about the contribution of genetic polymorphisms to the risk of VaD. Many candidate genetic polymorphisms have been examined in a large number of studies. However, due to the conflicting results, the genetics of VaD is still behind the shadow. OBJECTIVE: We conducted a comprehensive meta-analysis on associations between genetic polymorphisms of any gene and VaD to investigate the genetics of VaD. METHOD: We sought the published studies of associations between any genetic polymorphism and VaD and critically appraised them. We assessed the effects of genetic models by calculating pooled odds ratios (ORs), investigating the origin of heterogeneity by subgroup analysis, and testing the robustness by random effect model and sensitivity analysis. RESULTS: 69 studies with 4,462 cases and 11,583 controls were included. We identified APOE ɛ2/ɛ3/ɛ4 and additional four genetic polymorphisms including MTHFRC677T, PON1L55M, TGF-β1 +29C/T, and TNF-α -850C/T associated with VaD. Tested by random effect model and sensitivity analysis, the pooled results show nice robustness. CONCLUSIONS: Our comprehensive meta-analysis highlighted the genetic contribution to sporadic VaD. Because of the small amount of data on associations between genetic polymorphisms, except for APOE, and VaD, more studies are needed to test the existing genetic polymorphisms and detect other related genetic variants.
Authors: Sarah E Monsell; Charles Mock; David W Fardo; Sarah Bertelsen; Nigel J Cairns; Catherine M Roe; Sally R Ellingson; John C Morris; Alison M Goate; Walter A Kukull Journal: Alzheimer Dis Assoc Disord Date: 2017 Jul-Sep Impact factor: 2.703
Authors: Yuka A Martens; Na Zhao; Chia-Chen Liu; Takahisa Kanekiyo; Austin J Yang; Alison M Goate; David M Holtzman; Guojun Bu Journal: Neuron Date: 2022-03-16 Impact factor: 18.688
Authors: Erin R Kulick; Mitchell S V Elkind; Amelia K Boehme; Nina R Joyce; Nicole Schupf; Joel D Kaufman; Richard Mayeux; Jennifer J Manly; Gregory A Wellenius Journal: Environ Int Date: 2020-01-08 Impact factor: 9.621
Authors: Régis Bordet; Ralf Ihl; Amos D Korczyn; Giuseppe Lanza; Jelka Jansa; Robert Hoerr; Alla Guekht Journal: BMC Med Date: 2017-05-24 Impact factor: 8.775
Authors: M Arfan Ikram; Anna Bersano; Raquel Manso-Calderón; Jian-Ping Jia; Helena Schmidt; Lefkos Middleton; Benedetta Nacmias; Saima Siddiqi; Hieab H H Adams Journal: BMC Med Date: 2017-03-06 Impact factor: 8.775
Authors: Anders Wallin; Gustavo C Román; Margaret Esiri; Petronella Kettunen; Johan Svensson; George P Paraskevas; Elisabeth Kapaki Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472